Etiket: Mercks
Merck’s anti-COVID pill accused of accelerating virus mutations
Does Merck’s anti-COVID pill risk making the pandemic worse? Researchers claim that this treatment contributes to the emergence of mutations in the virus, with a risk for the moment theoretical:…
Levothyrox victims welcome Merck’s indictment for “aggravated deception”
A new episode in the pharmaco-judicial wisdom of Levothyrox:he French subsidiary of the German pharmaceutical company Merck announced on Wednesday October 19 in a press release its indictment for “aggravated…
WHO recommends molnupiravir, Merck’s antiviral pill, to certain patients at risk
States are not obliged to follow this recommendation. In France, the HAS did not grant authorization for this treatment last December. Article written by Posted on 03/03/2022 11:30 Update on…
Merck’s anti-COVID pill molnupiravir cleared in US
The Merck laboratory’s COVID-19 pill, intended for high-risk adults, was urgently authorized Thursday by the United States Medicines Agency (FDA), the day after the authorization of a similar pill developed…
Merck’s anti-Covid pill has just been urgently authorized in the United States
After the Pfizer pill, Merck’s treatment was authorized on Thursday across the Atlantic. It reduces the risk of hospitalization and death by 30% among the fragile population, according to initial…
Merck’s anti-Covid pill has just been urgently authorized in the United States
After the Pfizer pill, Merck’s treatment was authorized on Thursday. It reduces the risk of hospitalization and death by 30% among the fragile population, according to initial studies. Article written…
Merck’s COVID-19 pill cleared in US
The Merck laboratory’s COVID-19 pill, intended for high-risk adults, was urgently authorized Thursday by the United States Medicines Agency (FDA), the day after the authorization of a similar pill developed…
Generic versions | Agreement for global access to Merck’s anti-COVID-19 pill
(Geneva) The American laboratory Merck announced on Wednesday an agreement that could allow the widespread distribution in poor countries of generic versions of its anti-COVID-19 drug intended for people infected…
Agreement to allow global access to Merck’s anti-COVID pill
The American laboratory Merck announced on Wednesday an agreement that could allow the widespread distribution in poor countries of generic versions of its anti-COVID-19 drug intended for people infected with…
European Medicines Agency launches expedited review of Merck’s “molnupiravir”
If approved, this easy-to-administer remedy could become a crucial tool in the fight against the pandemic by reducing severe forms of the disease in addition to vaccination. Article written by…